258 related articles for article (PubMed ID: 34239048)
21. Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice.
Nakai N; Nagano M; Saitow F; Watanabe Y; Kawamura Y; Kawamoto A; Tamada K; Mizuma H; Onoe H; Watanabe Y; Monai H; Hirase H; Nakatani J; Inagaki H; Kawada T; Miyazaki T; Watanabe M; Sato Y; Okabe S; Kitamura K; Kano M; Hashimoto K; Suzuki H; Takumi T
Sci Adv; 2017 Jun; 3(6):e1603001. PubMed ID: 28691086
[TBL] [Abstract][Full Text] [Related]
22. Psychotic symptoms in 16p11.2 copy-number variant carriers.
Jutla A; Turner JB; Green Snyder L; Chung WK; Veenstra-VanderWeele J
Autism Res; 2020 Feb; 13(2):187-198. PubMed ID: 31724820
[TBL] [Abstract][Full Text] [Related]
23. Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model.
Gao Y; Aljazi MB; Wu Y; He J
Neurosci Lett; 2021 Nov; 764():136241. PubMed ID: 34509565
[TBL] [Abstract][Full Text] [Related]
24. GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.
Silverman JL; Pride MC; Hayes JE; Puhger KR; Butler-Struben HM; Baker S; Crawley JN
Neuropsychopharmacology; 2015 Aug; 40(9):2228-39. PubMed ID: 25754761
[TBL] [Abstract][Full Text] [Related]
25. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
[TBL] [Abstract][Full Text] [Related]
26. Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: Developmental aspects and effects of social context.
Sungur AÖ; Schwarting RK; Wöhr M
Autism Res; 2016 Jun; 9(6):696-709. PubMed ID: 26419918
[TBL] [Abstract][Full Text] [Related]
27. Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal.
Pomrenze MB; Cardozo Pinto DF; Neumann PA; Llorach P; Tucciarone JM; Morishita W; Eshel N; Heifets BD; Malenka RC
Neuron; 2022 Dec; 110(24):4125-4143.e6. PubMed ID: 36202097
[TBL] [Abstract][Full Text] [Related]
28. Sociability Deficits and Altered Amygdala Circuits in Mice Lacking Pcdh10, an Autism Associated Gene.
Schoch H; Kreibich AS; Ferri SL; White RS; Bohorquez D; Banerjee A; Port RG; Dow HC; Cordero L; Pallathra AA; Kim H; Li H; Bilker WB; Hirano S; Schultz RT; Borgmann-Winter K; Hahn CG; Feldmeyer D; Carlson GC; Abel T; Brodkin ES
Biol Psychiatry; 2017 Feb; 81(3):193-202. PubMed ID: 27567313
[TBL] [Abstract][Full Text] [Related]
29. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
Lacivita E; Niso M; Mastromarino M; Garcia Silva A; Resch C; Zeug A; Loza MI; Castro M; Ponimaskin E; Leopoldo M
ACS Chem Neurosci; 2021 Apr; 12(8):1313-1327. PubMed ID: 33792287
[TBL] [Abstract][Full Text] [Related]
30. Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice.
Kuteykin-Teplyakov K; Maldonado R
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1773-83. PubMed ID: 25241352
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder.
Sgritta M; Dooling SW; Buffington SA; Momin EN; Francis MB; Britton RA; Costa-Mattioli M
Neuron; 2019 Jan; 101(2):246-259.e6. PubMed ID: 30522820
[TBL] [Abstract][Full Text] [Related]
32. Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD.
Ebihara K; Fujiwara H; Awale S; Dibwe DF; Araki R; Yabe T; Matsumoto K
Behav Brain Res; 2017 Sep; 334():6-15. PubMed ID: 28743598
[TBL] [Abstract][Full Text] [Related]
33. Genetic control of social behavior: Lessons from mutant mice.
Provenzano G; Chelini G; Bozzi Y
Behav Brain Res; 2017 May; 325(Pt B):237-250. PubMed ID: 27825935
[TBL] [Abstract][Full Text] [Related]
34. Hyperactivity and male-specific sleep deficits in the 16p11.2 deletion mouse model of autism.
Angelakos CC; Watson AJ; O'Brien WT; Krainock KS; Nickl-Jockschat T; Abel T
Autism Res; 2017 Apr; 10(4):572-584. PubMed ID: 27739237
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Trpv4 rescues circuit and social deficits unmasked by acute inflammatory response in a Shank3 mouse model of Autism.
Tzanoulinou S; Musardo S; Contestabile A; Bariselli S; Casarotto G; Magrinelli E; Jiang YH; Jabaudon D; Bellone C
Mol Psychiatry; 2022 Apr; 27(4):2080-2094. PubMed ID: 35022531
[TBL] [Abstract][Full Text] [Related]
36. AST-001 Improves Social Deficits and Restores Dopamine Neuron Activity in a Mouse Model of Autism.
Um KB; Kwak S; Cheon SH; Kim J; Hwang SK
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137504
[TBL] [Abstract][Full Text] [Related]
37. Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective.
Sungur AÖ; Schwarting RKW; Wöhr M
Behav Brain Res; 2018 Oct; 352():46-61. PubMed ID: 28963042
[TBL] [Abstract][Full Text] [Related]
38. Combined the GABA-A and GABA-B receptor agonists attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Yang JQ; Yang CH; Yin BQ
Behav Brain Res; 2021 Apr; 403():113094. PubMed ID: 33359845
[TBL] [Abstract][Full Text] [Related]
39. Targeting oxytocin receptor (Oxtr)-expressing neurons in the lateral septum to restore social novelty in autism spectrum disorder mouse models.
Horiai M; Otsuka A; Hidema S; Hiraoka Y; Hayashi R; Miyazaki S; Furuse T; Mizukami H; Teruyama R; Tamura M; Bito H; Maejima Y; Shimomura K; Nishimori K
Sci Rep; 2020 Dec; 10(1):22173. PubMed ID: 33335150
[TBL] [Abstract][Full Text] [Related]
40. Chemical Modulators for Targeting Autism Spectrum Disorders: From Bench to Clinic.
Lim S; Lee S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
